Publicaciones en las que colabora con MARIONA JOVE FONT (20)

2023

  1. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  2. Metabolipidomic Analysis in Patients with Obstructive Sleep Apnea Discloses a Circulating Metabotype of Non-Dipping Blood Pressure

    Antioxidants, Vol. 12, Núm. 12

2022

  1. Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  2. Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles

    Advanced Functional Materials, Vol. 32, Núm. 29

  3. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

  4. Plasma profiling reveals a blood-based metabolic fingerprint of obstructive sleep apnea

    Biomedicine and Pharmacotherapy, Vol. 145

2021

  1. Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease

    Sleep, Vol. 44, Núm. 2

2020

  1. Gene expression and regulatory factors of the mechanistic target of rapamycin (mTOR) complex 1 predict mammalian longevity

    GeroScience, Vol. 42, Núm. 4, pp. 1157-1173

2019

  1. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  2. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  3. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2018

  1. Lipid Profile in Human Frontal Cortex Is Sustained Throughout Healthy Adult Life Span to Decay at Advanced Ages

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 73, Núm. 6, pp. 703-710

  2. Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 6193-6200

2017

  1. Differential metabolic profiles associated to movement behaviour of stream-resident brown trout (Salmo trutta)

    PLoS ONE, Vol. 12, Núm. 7

  2. Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1862, Núm. 5, pp. 485-495

  3. Sixty years old is the breakpoint of human frontal cortex aging

    Free Radical Biology and Medicine, Vol. 103, pp. 14-22

  4. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026

2016

  1. Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients

    EBioMedicine, Vol. 14, pp. 131-138

  2. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374

2015

  1. Metabolomics predicts stroke recurrence after transient ischemic attack

    Neurology, Vol. 84, Núm. 1, pp. 36-45